CV Sciences (CVSI) News Today → Gold Mania (From Stansberry Research) (Ad) Free CVSI Stock Alerts $0.04 +0.01 (+29.41%) (As of 05/3/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCV Sciences, Inc. (PNK:CVSI) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 1 at 7:04 PMCVSI Stock Earnings: CV Sciences Reported Results for Q4 2023investorplace.com - March 28 at 3:10 PMCV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Resultsprnewswire.com - March 28 at 9:00 AMCV Sciences Inc.wsj.com - March 27 at 9:29 AMCV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chewsfinance.yahoo.com - March 26 at 8:39 AMCV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2023 RESULTS ON MARCH 28, 2024prnewswire.com - March 21 at 9:00 AMCV Sciences Stock (OTC:CVSI), Short Interest Reportbenzinga.com - February 22 at 4:06 AMCV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market, Opening Door For European Distributionfinance.yahoo.com - December 12 at 9:52 AMThe Best Shampoo for Thinning Hair We Tested Is 30% Off Right Nownz.finance.yahoo.com - November 15 at 3:19 PMCV Sciences, Inc. (PNK:CVSI) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 15 at 3:19 PMHemp-Focused Wellness Company: Revenue Jumps To $4.1M, Gross Margin Peaks At 45.1%benzinga.com - November 14 at 3:22 PMCV Sciences GAAP EPS of $0.00, revenue of $4.09Mmsn.com - November 14 at 1:07 PMCV Sciences, Inc. Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 14 at 1:07 PMCV Sciences Inc CVSImorningstar.com - November 12 at 8:46 PMCV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023finance.yahoo.com - November 9 at 1:25 PMCV Sciences, Inc. Launches Reserve Sleep Gummiesfinance.yahoo.com - September 5 at 8:24 AMCV Sciences, Inc. (PNK:CVSI) Q2 2023 Earnings Call Transcriptfinance.yahoo.com - August 15 at 6:30 PMCV Sciences GAAP EPS of -$0.01, revenue of $4Mseekingalpha.com - August 14 at 4:38 PMPublicly Traded Hemp-Focused Wellness Company Reports Q2 Results, Here Is What You Need To Knowbenzinga.com - August 14 at 4:38 PMCV Sciences, Inc. Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 14 at 4:38 PMCV SCIENCES, INC. TO ANNOUNCE SECOND QUARTER 2023 RESULTS ON AUGUST 14, 2023finance.yahoo.com - August 1 at 4:45 PMCVSI - CV Sciences, Inc.finance.yahoo.com - July 8 at 7:18 AMCV Sciences to Participate in LD Micro Invitational Conferencefinance.yahoo.com - June 1 at 12:59 PMCV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Knowmsn.com - May 15 at 10:01 PMCV Sciences, Inc. Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 15 at 12:00 PMCV Sciences earnings: here's what Wall Street expectsmarkets.businessinsider.com - May 14 at 3:59 PMCV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023finance.yahoo.com - May 9 at 1:28 PMCV Sciences, Inc. (PNK:CVSI) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - April 9 at 8:25 PMCV Sciences, Inc. Introduces New THC Offeringfinance.yahoo.com - April 3 at 10:21 AMCV Sciences FY22 Revenue Declines 19% To $16.2Mmsn.com - March 29 at 2:54 PMCV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Resultsfinance.yahoo.com - March 29 at 9:54 AMCV Sciences is about to announce its earnings — here's what to expectmarkets.businessinsider.com - March 28 at 9:30 AMCV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023finance.yahoo.com - March 25 at 12:01 AMCV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addictionfinance.yahoo.com - March 23 at 2:24 PMCV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgelsfinance.yahoo.com - March 21 at 2:19 PMCV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigationbenzinga.com - March 4 at 3:02 PMCV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgelsfinance.yahoo.com - January 18 at 5:02 PMCV Sciences Stock (OTC:CVSI), Quotes and News Summarybenzinga.com - January 14 at 12:52 PMCV Sciences seeing strong consumer response to Reserve Collection and Wellness Line of productsproactiveinvestors.com - December 20 at 2:50 PMWhy Is CV Sciences Stock Up Today?msn.com - November 14 at 7:28 PMCV Sciences, Inc. (CVSI) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 14 at 7:28 PMCV Sciences, Inc. Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 14 at 10:21 AMCV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022finance.yahoo.com - November 8 at 7:38 PMCVSI CV Sciences, Inc.seekingalpha.com - October 1 at 9:07 AMCV Sciences, Inc. Extinguishes Convertible Debtfinance.yahoo.com - August 25 at 1:35 PMCV Sciences, Inc. Announces Launch of PlusCBD(TM) Reserve Collection Softgelsstockhouse.com - August 17 at 3:21 PMCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 15 at 11:35 PMCV Sciences, Inc. Reports Second Quarter 2022 Financial Resultsfinance.yahoo.com - August 15 at 11:35 PMCV Sciences, Inc. Announces Launch of PlusCBD™ Reserve Collection Softgelsfinance.yahoo.com - August 15 at 11:35 PMCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 16 at 3:46 PM Get CV Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CVSI and its competitors with MarketBeat's FREE daily newsletter. Email Address The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. CVSI Media Mentions By Week CVSI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVSI News Sentiment▼0.000.42▲Average Medical News Sentiment CVSI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVSI Articles This Week▼00▲CVSI Articles Average Week Get CV Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CVSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADXN News NCNA News EFTR News BNOX News CYCN News IMUN News CMMB News MCUJF News TENX News VIRI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CVSI) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CV Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
